Xibrom - ISTA Pharmaceuticals, Inc. - New Indication ApprovedXibrom is now also approved for the reduction of ocular pain in patients who have undergone cataract surgery.
Posted: January 2006
- Xibrom ISTA Pharmaceuticals, Inc. - Treatment for Ocular Inflammation Following Cataract Surgery - March 24, 2005
- FDA Accepts ISTA Pharmaceuticals' New Drug Application for Xibrom - July 26, 2004
- ISTA Pharmaceuticals Announces Submission of Xibrom NDA to the FDA - May 25, 2004